AlphAIAlphAI — Financial news for AI agents
SEC EDGAR$HNGE

Pursley James sold $3.1M of HNGE

Pursley James (President) sold 33,000 shares of Hinge Health, Inc. (HNGE) at an average of $94.14 ($93.37–$95.10, $3.11M total) across 3 trades on 2026-09-21 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Pursley James
Published Sep 23, 2026, 9:07 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 23, 2026, 9:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$HNGE
Bearish
medium confidence
Mentioned
$HNGE
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HNGEBearishLow
01

Why it matters

The sale reduces insider ownership but is modest; market reaction likely muted.

02

Market read

Primary relevance is to HNGE shareholders; limited spillover to sector.

03

What to watch

Sale executed via pre-arranged 10b5-1 plan, reducing informational value of the transaction.

Relevance 5/10Novelty 7/10Timing: after-hours filing on 2026-09-23

Background

Form 4 filings disclose insider transactions; investors monitor them for potential signals.

Company-level read

Ticker impact

$HNGEBearishMedium confidence
Context

President James Pursley sold 33,000 shares for $3.1M via a 10b5-1 plan, reducing his stake to 666,909 shares.

Expected impact

Modest short-term dip, 1-2% decline expected.

Evidence & confidence

Sale size is modest relative to market cap but involves a top executive; market may interpret as a negative signal.

Market effects

Sector

Minimal impact on digital health sector; no broader industry signal.

Regional

Limited to US market where HNGE trades.

Global

Low global relevance.

Counterpoint

What could challenge this read

Insider may be diversifying portfolio; sale does not necessarily indicate negative fundamentals.

Key entities

  • Company
    Hinge Health, Inc.

    Digital health platform listed as HNGE.

  • Executive
    Pursley James

    President of Hinge Health.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

HNGE insider trading history →

Related articles

$HNGEHighAI 8/10

Needham raises Hinge Health stock price target on client growth

Needham raised its price target for Hinge Health (NYSE:HNGE) to $135 from $115, citing strong client growth and quarterly performance. The company reported 28% year-over-year client growth, 50% revenue increase, and 154% stock return over six months. Q3 revenue was $235 million, up 52% year-over-year, with EPS of $0.66 beating estimates. Wells Fargo also raised its target to $132, noting strong margins and revenue growth.

investing.com
$HNGEHighAI 8/10

Hinge Health (HNGE) Q3 2026 Earnings Call Transcript

Hinge Health (HNGE) reported Q3 2026 revenue of $235M, up 52% YoY, with gross margin at 88% and operating income at $77M. The company highlighted growth in its MSK, Migraine, and GI care programs, with strong early results in Migraine care. President Jim Pursley announced his departure at year-end to spend more time with family but will join the board.

finance.yahoo.com